Aspen Shares Nosedive 15% on JSE After Shock Profit Warning
Aspen Pharmacare shares see a sharp decline on the JSE following an alarming profit warning. What does it mean for investors?
Adcock Ingram to Delist Amidst Corporate Changes
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
The Ascendis Health Turnaround: From Debt to Profitability
Explore the Ascendis Health turnaround, a journey from crippling debt to renewed profitability and strategic recovery.